跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
TRESIBA 100 UNIDADES/ML PENFILL SOLUCION INYECTABLE EN CARTUCHO
Approved
STANDARD
TRESIBA 100 UNIDADES/ML PENFILL SOLUCION INYECTABLE EN CARTUCHO
Novo Nordisk A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 2, 2020
Approval ID
e4df753bb9013efa
Company
Novo Nordisk A/S
Type
Standard
Approval Details
Approval Id
e4df753bb9013efa
Drug Cima Aemps Name
TRESIBA 100 UNIDADES/ML PENFILL SOLUCION INYECTABLE EN CARTUCHO
Register Number
1120807007
Holder Company Name
Novo Nordisk A/S
Marketing Company Name
Novo Nordisk Pharma S.A.
Holder Company Detail Path
/organization/novo-nordisk-a-s
Authorization Date
2020-09-02
Dosage Form
SOLUCIÓN INYECTABLE EN CARTUCHO
Dose
100 U/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novo Nordisk A/S
Company Detail Path
/organization/novo-nordisk-a-s
Company Information
Pharmaceutical Company Name
Novo Nordisk A/S
Name En
Novo Nordisk A/S
Country Name
Denmark
City Name
bagsværd,hovedstaden,country_dk
Address
Novo Alle 1
Website
https://www.novonordisk.com
Active Ingredients
INSULINA DEGLUDEC
100 U
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 2, 2020
Approval ID
e4df753bb9013efa
Type
Standard
Back to CIMA-AEMPS Approvals
TRESIBA 100 UNIDADES/ML PENFILL SOLUCION INYECTABLE EN CARTUCHO - CIMA-AEMPS Drug Approval Details